These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 33326735
21. Hypoxia-inducible factor-1α is involved in isoflurane-induced blood-brain barrier disruption in aged rats model of POCD. Cao Y, Li Z, Li H, Ni C, Li L, Yang N, Shi C, Zhong Y, Cui D, Guo X. Behav Brain Res; 2018 Feb 26; 339():39-46. PubMed ID: 28887194 [Abstract] [Full Text] [Related]
22. The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury. Higashida T, Kreipke CW, Rafols JA, Peng C, Schafer S, Schafer P, Ding JY, Dornbos D, Li X, Guthikonda M, Rossi NF, Ding Y. J Neurosurg; 2011 Jan 26; 114(1):92-101. PubMed ID: 20617879 [Abstract] [Full Text] [Related]
23. HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Yan J, Zhang Z, Shi H. Cell Mol Life Sci; 2012 Jan 26; 69(1):115-28. PubMed ID: 21617913 [Abstract] [Full Text] [Related]
24. HIF-1α is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis. Devraj G, Guérit S, Seele J, Spitzer D, Macas J, Khel MI, Heidemann R, Braczynski AK, Ballhorn W, Günther S, Ogunshola OO, Mittelbronn M, Ködel U, Monoranu CM, Plate KH, Hammerschmidt S, Nau R, Devraj K, Kempf VAJ. Acta Neuropathol; 2020 Aug 26; 140(2):183-208. PubMed ID: 32529267 [Abstract] [Full Text] [Related]
25. ATP-binding cassette (ABC) drug transporters in the developing blood-brain barrier: role in fetal brain protection. Eng ME, Imperio GE, Bloise E, Matthews SG. Cell Mol Life Sci; 2022 Jul 11; 79(8):415. PubMed ID: 35821142 [Abstract] [Full Text] [Related]
27. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model. Versele R, Sevin E, Gosselet F, Fenart L, Candela P. Int J Mol Sci; 2022 Sep 06; 23(18):. PubMed ID: 36142143 [Abstract] [Full Text] [Related]
28. Ramelteon Ameliorates LPS-Induced Hyperpermeability of the Blood-Brain Barrier (BBB) by Activating Nrf2. Liu Y, Wang L, Du N, Yin X, Shao H, Yang L. Inflammation; 2021 Oct 06; 44(5):1750-1761. PubMed ID: 33876343 [Abstract] [Full Text] [Related]
29. Ligustilide Ameliorates the Permeability of the Blood-Brain Barrier Model In Vitro During Oxygen-Glucose Deprivation Injury Through HIF/VEGF Pathway. Wu S, Wang N, Li J, Wang G, Seto SW, Chang D, Liang H. J Cardiovasc Pharmacol; 2019 May 06; 73(5):316-325. PubMed ID: 30855407 [Abstract] [Full Text] [Related]
32. Hypoxia-Induced miR-101 Impairs Endothelial Barrier Integrity Through Altering VE-Cadherin and Claudin-5. Shukla A, Bhardwaj U, Apoorva, Seth P, Singh SK. Mol Neurobiol; 2024 Mar 06; 61(3):1807-1817. PubMed ID: 37776496 [Abstract] [Full Text] [Related]
33. Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line. Ozgür B, Puris E, Brachner A, Appelt-Menzel A, Oerter S, Balzer V, Holst MR, Christiansen RF, Hyldig K, Buckley ST, Kristensen M, Auriola S, Jensen A, Fricker G, Nielsen MS, Neuhaus W, Brodin B. Fluids Barriers CNS; 2023 Dec 19; 20(1):96. PubMed ID: 38115090 [Abstract] [Full Text] [Related]
34. Differential responses of blood-brain barrier associated cells to hypoxia and ischemia: a comparative study. Engelhardt S, Huang SF, Patkar S, Gassmann M, Ogunshola OO. Fluids Barriers CNS; 2015 Feb 17; 12():4. PubMed ID: 25879623 [Abstract] [Full Text] [Related]
39. Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study. Conti A, Geffroy F, Kamimura HAS, Novell A, Tournier N, Mériaux S, Larrat B. Int J Mol Sci; 2022 Dec 07; 23(24):. PubMed ID: 36555129 [Abstract] [Full Text] [Related]
40. Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib. Goutal S, Gerstenmayer M, Auvity S, Caillé F, Mériaux S, Buvat I, Larrat B, Tournier N. J Control Release; 2018 Dec 28; 292():210-220. PubMed ID: 30415015 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]